Michael Becker, DO
Radiation Oncology · Las Vegas, NVNPI 1245247071
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations.
Across 35 payments — averaging $32.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$181
- Medtronic$164
- Pfizer$152
- Urogen Pharma, Inc.$125
- Antares Pharma, Inc.$117
- Blue Earth Diagnostics$87
- plus $319 from 10 others
What the payments were for
- Food & beverage$1,146100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 2 | $181 |
| Medtronic | 1 | $164 |
| Pfizer | 4 | $152 |
| Urogen Pharma, Inc. | 1 | $125 |
| Antares Pharma, Inc. | 4 | $117 |
| Blue Earth Diagnostics | 4 | $87 |
| Myovant Sciences Inc. | 5 | $80 |
| Astellas Pharma US Inc | 4 | $65 |
| Bayer | 3 | $49 |
| Dendreon Pharmaceuticals LLC | 1 | $22 |
| Sanofi | 1 | $21 |
| Palette Life Sciences, Inc. | 1 | $21 |
| Myriad Genetic Laboratories, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| AbbVie | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$164
- SpaceOAR VUE System - 10mL$128
- JELMYTO$125
How this compares
$1,146 in reported general payments places this provider in the 55th percentile of 47 radiation oncology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 12 | $31,982 |
| Bicalutamide | 257 | $4,476 |
| Tamsulosin Hcl | 344 | $3,534 |
| Finasteride | 83 | $1,136 |
| Venlafaxine Hcl | 65 | $635 |
| Megestrol Acetate | 23 | $532 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 17 | $453 |
| Ciprofloxacin Hcl | 53 | $175 |
| Sildenafil Citrate | 12 | $69 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Las Vegas
- Farzaneh FarzinLas Vegas$12K
- Samual FrancisLas Vegas$10K
- Ritchie StevensLas Vegas$9K
- Anita PomerantzLas Vegas$9K
- Michael SinopoliLas Vegas$5K
- Andrew CohenLas Vegas$4K
- Raul MeozLas Vegas$3K
- Wei Gang WangLas Vegas$2K
- Robert O LaughlinLas Vegas$2K
- Robert BeckLas Vegas$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.